Resorbable Magnesium Scaffolds Registry

Recruiting now

Conditions studied: Coronary Artery Disease

In brief

The registry follows the ESC/EACTS guideline and further investigates the clinical performance and short-term safety of RMS (Resorbable Magnesium Scaffolds) in a real world setting within the scope of its intended use without further (medical related) exclusion criteria according to their respective instructions for use (IFU).

Key facts

Study ID

NCT04679740

Run by

Biotronik AG

People needed

1106

Starts

2020-11-18

Expected to finish

2030-05-01

Last updated by the study team

2025-11-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• According to the IFU

You may not qualify if…

• According to the IFU

Where it is running

• Solothurner Spitäler AG — Olten, Switzerland (enrolling)
• Heart Center Segeberger Kliniken — Bad Segeberg, Germany (enrolling)
• Centro Cardiologico Monzino — Milan, Lombardy, Italy (enrolling)
• 1 Wojskowy Szpital Kliniczny z Poliklinika SPZOZ w Lublinie — Lublin, Poland (enrolling)
• Lindenhofspital — Bern, Switzerland (enrolling)
• Centre Hospitalier Universitaire Vaudois — Lausanne, Switzerland (enrolling)
• SUSCCH Banska Bystrica — Banská Bystrica, Slovakia
• Daugavpils Regional Hospital — Daugavpils, Latvia
• Cairns Hospital — Cairns, Australia
• Krankenhaus Buchholz — Buchholz, Germany
• Klinikum Westfalen, Knappschaft KH — Dortmund, Germany
• Klinikum Herford — Herford, Germany
• Herz-und Gefäßzentrum Oberallgäu-Kempten — Kempten, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.